
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Thorsten Strahl is supervisor protein and scientific officer with Charles River.

Gene therapy products present a unique set of challenges for the control of host cell protein impurities.

Published: July 15th 2021 | Updated: